|
Status |
Public on Oct 07, 2022 |
Title |
Prostate cancer resistance leads to a global deregulation of translation factors and unconventional translation |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Other
|
Summary |
Using a newly generated enzalutamide-resistant prostate cancer model, we characterized alterations in the translatome during prostate cancer enzalutamide resistance acquisition. We show a discordance between the translatome and transcriptome of drug-resistant cells, a deregulation of proteins involved in translation and an overall decrease in translational efficiency upon resistance acquisition. Interestingly, long non-coding RNAs show higher translation efficiency in enzalutamide-resistant cells, and a strong correlation with poor patient prognosis. Taken together, this suggests that aberrant translation of coding and non-coding genes are strong indicators of PCa enzalutamide-resistance.
|
|
|
Overall design |
RNA sequencing of Poly(A) RNA from enzalutamide sensitive VCaP and VCaP-CRPC (Castration Resistant Prostate Cancer) and of enzalutamide resistant VCaP-ER (Enzalutamide Resistant), and RNA sequencing of heavy polysome-bound RNA from VCaP-CRPC and VCaP-ER (as duplicates).
|
|
|
Contributor(s) |
Lelong EJ, Khelifi G, Hussein SI |
Citation(s) |
36348939 |
|
Submission date |
Jun 29, 2021 |
Last update date |
Nov 21, 2022 |
Contact name |
Samer M.I. Hussein |
E-mail(s) |
samer.hussein@fmed.ulaval.ca
|
Organization name |
CHU de Québec - Université Laval
|
Department |
Departement of medecine
|
Lab |
Hussein Lab
|
Street address |
9 rue Mcmahon
|
City |
Quebec City |
State/province |
Quebec |
ZIP/Postal code |
G1R 3S3 |
Country |
Canada |
|
|
Platforms (1) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
Samples (10)
|
|
Relations |
BioProject |
PRJNA742424 |
SRA |
SRP326162 |